Table-II.

Visual increase with respect to various demographic and clinical characteristics.

	N	Pre Operative BCVA	Post Operative BCVA	P-Value
Overall	30	0.737±0.294	0.510±0.387	0.000	P<0.01
Gender
Male	12	0.825±0.282	0.614±0.398	0.000	P<0.01
Female	18	0.678±0.295	0.441±0.375	0.000	P<0.01
Size of macular hole
≤400µm	13	0.469±0.143	0.176±0.116	0.000	P<0.01
>400µm	17	0.942±0.197	0.765±0.321	0.000	P<0.01
Duration of symptoms
≤ 16 weeks	17	0.558±0.212	0.258±0.197	0.000	P<0.01
> 16 weeks	13	0.973±0.214	0.839±0.324	0.002	P<0.01
Lens Status
Phakic	20	0.660±0.281	0.423±0.347	0.000	P<0.01
Pseudophakic	10	0.891±0.270	0.684±0.423	0.003	P<0.01
Stages of macular hole
Stage 2	13	0.4692±0.143	0.1769±0.116	0.000	P<0.01
Stage 3	11	0.912±0.218	0.724±0.325	0.001	P<0.01
Stage 4	6	0.996±0.157	0.840±0.328	0.097	P>0.01
Complication after Macular Surgery
Yes	19	0.832±0.287	0.642±0.398	0.000	P<0.01
No	11	0.572±0.237	0.281±0.244	0.000	P<0.01

Paired t-test applied. P-value<0.05 considered as significant.